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A new Cd(II) complex with the ligand 4 -chloro-2,2 6 ,2  -terpyridine (Cltpy), [Cd(Cltpy)(I)2], has been synthesized and
characterized by CHN elemental analysis, 1H-NMR, 13C-NMR, and IR spectroscopy and structurally analyzed by X-ray single-
crystal diﬀraction. The single-crystal X-ray analyses show that the coordination number in complex is ﬁve with three terpyridine
(Cltpy) N-donor atoms and two iodine atoms. The antibacterial activities of Cltpy and its Cd(II) complex are tested against
diﬀerent bacteria.
1.Introduction
Terpyridine molecules with three nitrogen atoms acting as
tridentateligandstocoordinatewithvarioustransition metal
ions have been extensively studied [1, 2]. Coordination
chemistry of the multitopic ligand of 2,2 :6 ,2   terpyridine
(tpy)particularly thosesubstitutedatthe4-positionhasbeen
recently attracting growing attention in the design of the
supramolecular building blocks based on the metaldirected
self-assembly [3–26]. The 4 -chloro-2,2 :6 ,2  -terpyridine
(Cltpy) ligand (Figure 1) contains one widely used tpy
coordinative site and the other Cl site at the 4 -position.
These twositesare abletobindwithdiﬀerentmetalions,thus
leading to the coordination polymers with various frame-
works [21]. Tpy can bind to both low- and high-oxidation
state metal ions, almost always in tridentate fashion [27–
32]. The synthesis of tpy derivatives has been extensively
studied by Constable’s group, and varieties of substituted
tpy compounds have been reported [19, 20]. For example,
they oﬀered interesting prospects for metal-activated drug
delivery system, where the activity could be switched by
metal-ion coordination throughthe study of the interactions
between bioreceptorsand ligand with sugar substituents [19,
20]. In clinical applications and biochemistry, functionalized
terpyridines have found a wide range of potential uses,
ranging from colorimetric metal determination to DNA
binding agents [33]. Metal terpyridine complexes due to the
binding to nucleic acids have the ability or potential to serve
as anticancer, antibacterial, and antiparasitic drugs [34–39].
The exact mechanisms are not known in some cases and
may involve protein binding or membrane binding. The
interaction Cd(II) ion with biomolecules is one of the most
studying ﬁelds in coordination chemistry, and cadmium is a
verytoxicmetalandwidelyusedinmanyindustrialprocesses
[40, 41]. In this research we used new tridentate ligand 4 -
chloro-2,2 :6 ,2  -terpyridine (Cltpy) that has been used for
synthesis of a new cadmium(II) complex. The structural
and biological properties of this new complex have been
studied.2 Bioinorganic Chemistry and Applications
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Figure 1: Structure of Cltpy ligand.
2.Experimental
2.1. Materials and Measurements. All chemicals were reagent
grade and used without further puriﬁcation. Elemental anal-
yses (CHN) were performed using a Carlo ERBA model
EA 1108 analyzer. FT-IR spectra were collected on a Shi-
madzu prestige 21 spectrophotometer in the range of 4000–
400cm−1 using KBr pellets. 1Ha n d13C NMR spectra were
recorded with a Bruker spectrometer at 250MHz in D6-
DMSO.
2.2. Preparation of [Cd(Cltpy)(I)2]. 4 -chloro-2,2 :6 ,2  -ter-
pyridine (0.268g, 1mmol) was placed in one arm of a
branched tube, cadmium(II) acetat (0.264g, 1mmol) and
potassium iodide (0.332g, 2mmol) in the other. Methanol
was carefully added to ﬁll both arms, the tube was then
sealed, and the ligand-containing arm was immersed in
ab a t ha t6 0 ◦C, while the other remained at ambient
temperature. After two days, the light brown crystals that
had deposited in the cooler arm were ﬁltered oﬀ,t h e n
washed with diethylether, and air dried. Yield: 71%. Anal-
ysis: found: C: 28.38, H: 1.51, N: 6.59%. Calculated for
C15H10CdClI2N3: C: 28.42, H: 1.59, N, 6.63%. IR (cm−1)
selected bonds: 679(w), 798(s), 822(m), 1005(m), 1142(w),
1405(s), 1475(m), 1545(s), 1582(s), 3042(w), 3065(w). 1H
NMR (DMSO, δ): 7.49 (t, 2H), 8.011 (t, 2H), 8.404 (s, 2H),
8.684 (m, 4H)ppm. 13CN M R(DMSO, δ): 120.46, 121.06,
124.34, 135.31, 140.65, 146.52, 152.12, 155.36ppm.
2.3. Antibacterial Activity Test. In vitro activity test was
carried out using the growth inhibitory zone (well method)
[42–45].The potencyofcomponentswasdeterminedagainst
the three Gram-positive bacteria, Streptococcus pyogenes
(RITCC 1940), Staphylococcus aureus (RITCC 1885), and
Bacillus anthracis (RITCC 1036), and also against the
three Gram-negative bacteria, Klebsiella pneumonia (RITCC
1249), Escherichia coli (RITCC 1330), and Pseudomonas
aeruginosa (RITCC 1547). Microorganisms (obtained from
enrichment culture of the microorganisms in 1mL Muller-
Hinton broth incubated at 37◦C for 12h) were cultured on
Muller-Hinton agar medium. The inhibitory activity was
compared with that of standard antibiotics, such as gentam-
icin(10μg).Afterdrilling wells on themediumusing a 6mm
Table 1: Crystallographic data of [Cd(Cltpy)I2 complex.
Identiﬁcation code Cd (terpy-Cl) I2 (7)
Empirical formula C15 H10 Cd Cl I2 N3
Formula weight 633.91
Colour light brown
Temperature 293(2) K
Wavelength 0.71073 A
Crystal system Monoclinic
Space group P2(1)/c
Unit cell dimensions a = 11.4865(10) ˚ A
b = 8.9326(7) ˚ A
c = 17.7570(14) ˚ A
α = 90◦
β = 94.242(2)◦
γ = 90◦
Volume 1817.0(3) ˚ A3
Z4
Density (calculated) 2.317 g cm−3
Absorption coeﬃcient 4.745 mm−1
F(000) 1168
Crystal size 0.27 × 0.14 ×0.13 mm3
Theta range for data collection 1.78 to 25.02◦
Index ranges −11 ≤ h ≤ 13
−10 ≤ k ≤ 10
−21 ≤ l ≤ 19
Reﬂections collected 9236
Independent reﬂections 3184
Absorption correction Empirical
Max. and min. transmission 0.5774 and 0.3606
Reﬁnement method Full-matrix
least-squares on F2
Data/restraints/parameters 3184/0/199
Goodness-of-ﬁt on F2 1.063
Final R indices [I > 2σ (I)] R1 = 0.0309
wR2 = 0.0747
R indices (all data) R1 = 0.0504
wR2 = 0.0862
Largest diﬀ. peak, hole 0.802 and −0.708e· ˚ A−3
cork borer, 100μL of solution from diﬀerent compounds
were poured into each well. The plates were incubated at
37◦C overnight. The diameter of the inhibition zone was
measured as precisely as possible. Each test was carried out
in triplicate, and the average was calculated for inhibition
zone diameters. A blank containing only DMSO showed no
inhibition in a preliminary test. The macrodilution broth
susceptibility assay was used for the evaluation of minimal
inhibitory concentration (MIC). The use of 12 test tubes is
required by the macrodilution method. By including 1mL
Muller-Hinton broth in each test and then adding 1mL
extract with concentration 100mg/mL in the ﬁrst tube, we
made a serial dilution of this extract from the ﬁrst tube to
the last tube. Bacterial suspensions were prepared to matchBioinorganic Chemistry and Applications 3
θ1 = N(2)-Cd(1)-N(1)
θ2 = N(2)-Cd(1)-N(3)
θ3 = N(2)-Cd(1)-I(1)
θ4 = N(2)-Cd(1)-I(2)
θ5 = N(1)-Cd(1)-I(1)
θ6 = N(1)-Cd(1)-I(2)
θ7 = N(3)-Cd(1)-I(1)
θ8 = N(3)-Cd(1)-I(2)
θ9 = N(3)-Cd(1)-N(1)
θ10 = I(1)-Cd(1)-I(2)
Cl1
N1
I1
I2
N3
Cd1
N2
Figure 2: Molecular structure of [Cd(Cltpy)I2] including the atom
numbering scheme. All hydrogen atoms have been omitted for
clarity.
the turbidityof0.5 McFarland turbidity standards. Matching
this turbidity provided bacterial inoculums concentration of
1.5 × 108 cfu/mL. Then 1mL of bacterial suspension was
added to each test tube. After incubation at 37◦Cf o r2 4h ,
the last tube was determined as the minimal inhibitory
concentration (MIC) without turbidity.
2.4. X-Ray Crystallography
2.4.1. Structure Determination. Data collection for X-ray
crystal structure determination was performed on a STOE
IPDS I/II diﬀractometer using graphite-monochromated
Mo-Kα radiation (λ = 0.71073 ´ ˚ A). The data were corrected
for Lorentz and polarization eﬀects. A numerical absorption
correction based on crystal-shape optimization was applied
for all data. The programs used in this work are Stoe’s X-
Area, including X-RED and X-Shape for data reduction and
absorption correction, and the WinGX suite of programs,
including Sir-92 and Shelxl-97 for structure solution and
reﬁnement [46]. The hydrogen atoms were placed in ideal-
ized positions and constrained to ride on their parent atom.
Thelastcyclesofreﬁnement includedatomicpositions forall
atoms, anisotropic thermal parameters for all nonhydrogen
atoms, and isotropic thermal parameters for all hydrogen
atoms. Materials for publication were prepared by using
Mercury and Ortep-3 [47, 48]. The summary of the crystal
data,experimental details,and reﬁnement resultsofcomplex
is listed in Table 1.
3.Resultsand Discussion
3.1. Spectroscopic Studies. The reaction of CdX2 (X: nitrate
and acetate) with 4 -chloro-2,2 :6 ,2  -terpyridine (Cltpy)
and potassiumiodideyieldedcrystalline material formulated
as [Cd(Cltpy)(I)2]. The IR spectra display characteristic ab-
sorption bands for the tpyCl ligands. The relatively weak ab-
sorption bands at around 3042–3065cm−1 are due to the C–
H modes involving the aromatic ring hydrogen atoms. The
absorption bands with variable intensity in the frequency
Table 2: Selected bond lengths/˚ Aa n da n g l e s / ◦.
[Cd(Cltpy)I2]
Cd1–N1 2.373(5) θ3 135.19(11)
Cd1–N2 2.331(5) θ4 106.17(11)
Cd1–N3 2.381(5) θ5 101.35(12)
Cd1–I1 2.7311(8) θ6 101.13(13)
Cd1–I2 2.7523(7) θ7 101.33(13)
θ8 99.34(13)
θ1 69.24(17) θ9 130.94(18)
θ2 68.81(18) θ10 118.63(2)
range 1400–1620cm−1 correspond to aromatic ring vibra-
tions of the tpyCl ligand [29–40, 49].
The 1H-NMR spectra of DMSO solutions of complex
at room temperature show two triplets, a singlet, and a
multiplet for the aromatic protons of Cltpy ligand. The 13C-
NMR spectra of DMSO solutions of these compounds show
eight distinct bands assigned to the aromatic carbon atoms
of the pyridine rings of the Cltpy ligand.
3.2. Structural Analysis. The solid-state structure of com-
pound was determined by single-crystal X-ray diﬀraction.
Crystal and structure reﬁnement data of the compound are
g i v e ni nT a b l e1. X-ray crystal analysis reveals that the com-
pound crystallizes in monoclinic with space group P2(1)/c.
The crystal structure of compound consists of monomeric
units. Each cadmium atom chelated by three Cltpy nitrogen
atoms and two iodine atoms (Figure 2). The resulting coor-
dination number of ﬁve is augmented with CdN3I2 molecule
core. Selected bond lengths and angels of complex are given
in Table 2.
The complex structure was described in detail. Five coor-
dinate complexes with chelating ligands can exhibit either
square pyramidal or trigonal bipyramidal geometries, and
the particular case is inﬂuenced by both steric and electronic
factors. The variation of ﬁve coordinate species between
square pyramidal and trigonal bipyramidal is quantiﬁed
using τ values calculated by (1), where β is the largest X–
Cu–X bond angle and α is the second largest X–Cu–X angle.
For the regular square pyramidal structures the trigonality
parameterτ will bezero, anditincreases to1.0as thetrigonal
bipyramidal distortion increases [50–52]:
τ =

β − α

60
. (1)
The new [Cd(Cltpy)(I)2] complex reported herein takes on
a slightly distorted square pyramidal structure as evidenced
by the τ value of 0.029. Deﬁnition of the bond angles (θ)i n
[Cd(Cltpy)(I)2] complex is illustrated in Figure 1.T h eC d 1 –
N1, Cd1–N2, and Cd1–N3 bond lengths are within the nor-
mal range of Cd–N bonds. The average bond length of Cd–I
is 2.7417(7) ˚ A that is slightly shorter than the reported bond
length [53]. The I2 occupies the apical position in complex
at relatively longer distance. The rigid character of the tpy
bite leads Cd–N bond lengths in the complex to follow the
generaltrend of Cdtpycomplexes,that is, to havetheirCd–N4 Bioinorganic Chemistry and Applications
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Figure 3: (a) The unit cell of [Cd(Cltpy)I2]. (b) Close-up view of the aromatic π-π contacts showing ligand overlap (slipped face-to-face
interaction).
Table 3: Intermolecular interactions in crystals of [Cd(Cltpy)I2]c o m p l e x .
A···H-B H···A/˚ AB ···A/˚ AB - H ···A/◦
I2···H14–C14(−x, y, −z +1/2) 2.937 3.620(2) 166.16
I2···H12–C12(−x, y, −z +1/2) 3.130 3.435(2) 161.15
I2···H13–C13(−x, y, −z +1/2) 3.163 3.308(2) 135.50
C2(N1C1–C5)···C8(N2C6–C10) 3.472(3)
Centroid···centroid (N1C1–C5)··· (N2C6–C10) 3.818(2)
Centroid···centroid (N3C11–C15)··· (N3C11–C15) 4.275(2)
Table 4:Antibacterial activities (zoneofgrowth inhibitionandminimalinhibitory concentrations)ofCltpy ligandandCd (II)complex and
gentamicin (as a standard compound).
Method Main compounds
Microorganisms
Klebsiella
pneumonia (−)
Escherichia
coli (−)
Pseudomonas
aeruginosa (−)
Streptococcus
pyogenes (+)
B. anthracis
(+)
Staphyeococcus
aureus (+)
Growth Inhibitory
zone [mm]
Cltpy 10 15 20 30 25 15
Complex 10 20 20 10 12 10
Standard Gentamicin 20 25 15 13 32 20
Minimum inhibitory
concentration
(mg/mL) (MIC)
L 100 100 50 6.25 12.5 100
Complex 100 50 50 100 100 100
central bond slightly shorter than the Cd–N lateral [54, 55].
The tpy ligand is not planar; due to coordination strain
the molecule is bent into a concaveshape, the central pyridyl
group subtending dihedral angles of 5.85(1) and 9.19(1)◦ to
the lateral ones.
This complex has some intermolecular interactions.
Intermolecular interactions in crystal of [Cd(Cltpy)I2]c o m -
plex are shown in Table 3. There are aromatic π-π stacking
interactions between the parallel aromatic rings of the
4 -chloro-2,2 :6 ,2  -terpyridine (Cltpy) ligands as seen in
Figure 3(b).
T h eu n i tc e l lo fc o m p l e xi ss h o w ni nF i g u r e2. Molecules
occupiedhalfoftetrahedral holesand usedzincblendsystem
that is not a closed packed system.
3.3. Antibacterial Activity. The antibacterial activities of
Cltpy and its Cd(II) complex are shown in Table 4.T h e
free ligand has considerable activity against Staphylococcus
pyogenes, Bacillus anthracis, and Pseudomonas aeruginosa
(inhibitory zones ≥20mm) buthas moderateactivity against
Escherichia coli and Streptococcus aureus (inhibitory zones
≤15mm) [42, 43]. In comparison with free Cltpy ligand,
the complex has more activity against Escherichia coli (more
inhibitory zones), but it is less active against Staphylococcus
pyogenes, Bacillus anthracis, and Streptococcus aureus,[ 45].
It is should be noticed that the antibacterial activity of
Cltpy ligand is higher than standard antibiotic (gentamicin)
against Pseudomonas aeruginosa, Streptococcus pyogenes, and
Klebsiella pneumonia.Bioinorganic Chemistry and Applications 5
Against Escherichia coli, antibacterial activity of complex
is higher than Cltpy ligand. The higher activity of complex
may be explained on the basis of chelation theory [42, 43].
Also the better antibacterial activity of complex is probably
due to the existence of I−anion in its structure [44, 45].
The quantitative assays gave MIC values in the range 50–
100mgml−1 (Table 4) that conﬁrmed the previous results.
4.Conclusion
New multidentate ligand, 4 -chloro-2,2 :6 ,2  -terpyridine
(Cltpy), has been used for preparation of an inorganic
complex. A new Cd(II) complex [Cd(Cltpy)I2] has been
synthesized and characterized by CHN elemental analysis,
1H-NMR, 13C-NMR, and IR spectroscopy, and structurally
analyzed by X-ray single-crystal diﬀraction. The single-
crystal X-ray analyses show that the coordination number in
this complex is ﬁve with three terpyridine (Cltpy) N-donor
atoms and two iodine atoms. The antibacterial activities of
Cltpy and its Cd(II) complex are tested against diﬀerent
bacteria. The complex has good activity against all tested
bacteria. Against Escherichia coli, antibacterial activity of
complex is higher than Cltpy ligand. The higher activity of
complex may be explained on the basis of chelation theory.
AdditionalData
CCDC reference number 799987 contains the additional
crystallographic data for thisp a p e r .T h e s ed a t ac a nb eo b -
tained free of charge at http://www.ccdc.cam.ac.uk/conts/re-
trieving.html.
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